Morgan Stanley Maintains Underweight on Adient, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Adam Jonas maintains an Underweight rating on Adient (NYSE:ADNT) and lowers the price target from $32 to $21.
August 14, 2024 | 2:54 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley analyst Adam Jonas maintains an Underweight rating on Adient and lowers the price target from $32 to $21.
The lowered price target and maintained Underweight rating by a reputable analyst from Morgan Stanley is likely to negatively impact investor sentiment and short-term stock price of Adient.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100